# Molecular Diagnostic Platform for AML

> **NCT04446741** · — · UNKNOWN · sponsor: **PETHEMA Foundation** · enrollment: 2000 (estimated)

## Conditions studied

- Acute Myeloid Leukemia (AML)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04446741
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04446741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04446741, "Molecular Diagnostic Platform for AML". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04446741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*